Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2026-01-02 @ 3:42 AM
Study NCT ID:
NCT04025450
Status:
RECRUITING
Last Update Posted:
2019-07-19
First Post:
2019-07-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-07-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-07-15
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-17
First Submit QC Date:
None
Study First Post Date:
2019-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-17
Last Update Post Date:
2019-07-19
Last Update Post Date Type:
ACTUAL